Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Hyungwoo Cho

Clinical trials sponsored by Hyungwoo Cho, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Experimental CAR-T therapy targets Hard-to-Treat brain cancer Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Experimental CAR-T therapy targets Hard-to-Treat brain cancer

Disease control Recruiting now

This pilot study is testing a new treatment called Anbal-cel for people with relapsed or refractory primary or secondary central nervous system lymphoma. Anbal-cel is a CAR-T cell therapy made from the patient's own immune cells. The study will enroll 12 participants to see if th…

Phase 2 • Sponsor: Hyungwoo Cho • Aim: Disease control

Last updated Jun 27, 2026 08:04 UTC